vs
Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and HALOZYME THERAPEUTICS, INC. (HALO). Click either name above to swap in a different company.
HALOZYME THERAPEUTICS, INC. is the larger business by last-quarter revenue ($451.8M vs $233.0M, roughly 1.9× CSW INDUSTRIALS, INC.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -31.3%, a 35.7% gap on every dollar of revenue. On growth, HALOZYME THERAPEUTICS, INC. posted the faster year-over-year revenue change (51.6% vs 20.3%). HALOZYME THERAPEUTICS, INC. produced more free cash flow last quarter ($217.6M vs $22.7M). Over the past eight quarters, HALOZYME THERAPEUTICS, INC.'s revenue compounded faster (51.9% CAGR vs 5.1%).
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
CSW vs HALO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $233.0M | $451.8M |
| Net Profit | $10.3M | $-141.6M |
| Gross Margin | 39.7% | 82.6% |
| Operating Margin | 7.4% | -20.6% |
| Net Margin | 4.4% | -31.3% |
| Revenue YoY | 20.3% | 51.6% |
| Net Profit YoY | -61.9% | -203.3% |
| EPS (diluted) | $0.62 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $233.0M | $451.8M | ||
| Q3 25 | $277.0M | $354.3M | ||
| Q2 25 | $263.6M | $325.7M | ||
| Q1 25 | $230.5M | $264.9M | ||
| Q4 24 | $193.6M | $298.0M | ||
| Q3 24 | $227.9M | $290.1M | ||
| Q2 24 | $226.2M | $231.4M | ||
| Q1 24 | $210.9M | $195.9M |
| Q4 25 | $10.3M | $-141.6M | ||
| Q3 25 | $40.7M | $175.2M | ||
| Q2 25 | $40.9M | $165.2M | ||
| Q1 25 | $35.1M | $118.1M | ||
| Q4 24 | $26.9M | $137.0M | ||
| Q3 24 | $36.1M | $137.0M | ||
| Q2 24 | $38.6M | $93.2M | ||
| Q1 24 | $31.8M | $76.8M |
| Q4 25 | 39.7% | 82.6% | ||
| Q3 25 | 43.0% | 84.4% | ||
| Q2 25 | 43.8% | 85.8% | ||
| Q1 25 | 44.2% | 81.7% | ||
| Q4 24 | 41.4% | 85.9% | ||
| Q3 24 | 45.6% | 83.0% | ||
| Q2 24 | 47.5% | 82.9% | ||
| Q1 24 | 44.4% | 85.5% |
| Q4 25 | 7.4% | -20.6% | ||
| Q3 25 | 20.5% | 61.5% | ||
| Q2 25 | 20.8% | 62.2% | ||
| Q1 25 | 19.5% | 53.4% | ||
| Q4 24 | 15.3% | 58.9% | ||
| Q3 24 | 22.6% | 56.3% | ||
| Q2 24 | 24.3% | 50.7% | ||
| Q1 24 | 21.0% | 48.8% |
| Q4 25 | 4.4% | -31.3% | ||
| Q3 25 | 14.7% | 49.5% | ||
| Q2 25 | 15.5% | 50.7% | ||
| Q1 25 | 15.2% | 44.6% | ||
| Q4 24 | 13.9% | 46.0% | ||
| Q3 24 | 15.8% | 47.2% | ||
| Q2 24 | 17.1% | 40.3% | ||
| Q1 24 | 15.1% | 39.2% |
| Q4 25 | $0.62 | $-1.13 | ||
| Q3 25 | $2.41 | $1.43 | ||
| Q2 25 | $2.43 | $1.33 | ||
| Q1 25 | $2.05 | $0.93 | ||
| Q4 24 | $1.60 | $1.06 | ||
| Q3 24 | $2.26 | $1.05 | ||
| Q2 24 | $2.47 | $0.72 | ||
| Q1 24 | $2.03 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.2M | $133.8M |
| Total DebtLower is stronger | — | $2.1B |
| Stockholders' EquityBook value | $1.1B | $48.8M |
| Total Assets | $2.3B | $2.5B |
| Debt / EquityLower = less leverage | — | 43.89× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.2M | $133.8M | ||
| Q3 25 | $31.5M | $419.7M | ||
| Q2 25 | $38.0M | $61.9M | ||
| Q1 25 | $225.8M | $176.3M | ||
| Q4 24 | $213.8M | $115.8M | ||
| Q3 24 | $273.2M | $154.3M | ||
| Q2 24 | $18.9M | $187.9M | ||
| Q1 24 | $22.2M | $164.6M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | $800.1M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $166.0M | $1.5B |
| Q4 25 | $1.1B | $48.8M | ||
| Q3 25 | $1.1B | $503.9M | ||
| Q2 25 | $1.1B | $332.7M | ||
| Q1 25 | $1.1B | $482.3M | ||
| Q4 24 | $1.0B | $363.8M | ||
| Q3 24 | $1.0B | $452.7M | ||
| Q2 24 | $650.2M | $289.4M | ||
| Q1 24 | $615.7M | $177.8M |
| Q4 25 | $2.3B | $2.5B | ||
| Q3 25 | $1.5B | $2.2B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.4B | $2.2B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.4B | $2.1B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $1.0B | $1.8B |
| Q4 25 | — | 43.89× | ||
| Q3 25 | — | 3.00× | ||
| Q2 25 | — | 4.54× | ||
| Q1 25 | 0.75× | 3.13× | ||
| Q4 24 | — | 4.14× | ||
| Q3 24 | — | 3.32× | ||
| Q2 24 | — | 5.19× | ||
| Q1 24 | 0.27× | 8.44× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $219.0M |
| Free Cash FlowOCF − Capex | $22.7M | $217.6M |
| FCF MarginFCF / Revenue | 9.8% | 48.2% |
| Capex IntensityCapex / Revenue | 2.6% | 0.3% |
| Cash ConversionOCF / Net Profit | 2.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | $162.0M | $644.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.9M | $219.0M | ||
| Q3 25 | $61.8M | $178.6M | ||
| Q2 25 | $60.6M | $99.7M | ||
| Q1 25 | $27.3M | $154.2M | ||
| Q4 24 | $11.6M | $178.5M | ||
| Q3 24 | $66.8M | $115.4M | ||
| Q2 24 | $62.7M | $55.8M | ||
| Q1 24 | $22.4M | $129.4M |
| Q4 25 | $22.7M | $217.6M | ||
| Q3 25 | $58.7M | $175.6M | ||
| Q2 25 | $57.7M | $98.1M | ||
| Q1 25 | $22.8M | $153.3M | ||
| Q4 24 | $8.5M | $175.4M | ||
| Q3 24 | $61.3M | $113.9M | ||
| Q2 24 | $59.6M | $53.2M | ||
| Q1 24 | $17.5M | $125.9M |
| Q4 25 | 9.8% | 48.2% | ||
| Q3 25 | 21.2% | 49.6% | ||
| Q2 25 | 21.9% | 30.1% | ||
| Q1 25 | 9.9% | 57.9% | ||
| Q4 24 | 4.4% | 58.9% | ||
| Q3 24 | 26.9% | 39.3% | ||
| Q2 24 | 26.3% | 23.0% | ||
| Q1 24 | 8.3% | 64.3% |
| Q4 25 | 2.6% | 0.3% | ||
| Q3 25 | 1.1% | 0.9% | ||
| Q2 25 | 1.1% | 0.5% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 1.6% | 1.0% | ||
| Q3 24 | 2.4% | 0.5% | ||
| Q2 24 | 1.4% | 1.1% | ||
| Q1 24 | 2.3% | 1.8% |
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | 1.02× | ||
| Q2 25 | 1.48× | 0.60× | ||
| Q1 25 | 0.78× | 1.31× | ||
| Q4 24 | 0.43× | 1.30× | ||
| Q3 24 | 1.85× | 0.84× | ||
| Q2 24 | 1.62× | 0.60× | ||
| Q1 24 | 0.71× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
